SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001169245-21-000064
Filing Date
2021-06-04
Accepted
2021-06-04 18:14:28
Documents
1
Period of Report
2021-06-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_162284484859159.html 4  
1 FORM 4 wf-form4_162284484859159.xml 4 3990
  Complete submission text file 0001169245-21-000064.txt   5595
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Issuer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DOVA PHARMACEUTICALS, INC. 240 LEIGH FARM ROAD, SUITE 245 DURHAM NC 27707
Business Address
Sapir Alex (Reporting) CIK: 0001709415 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38697 | Film No.: 21997733